Cargando…

A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report

RATIONALE: Alport syndrome (AS) is an inherited progressive renal failure, characterized by kidney disease, hearing loss, and eye abnormalities. PATIENT CONCERNS: A 7-year-old male child was admitted for persistent microscopic hematuria and proteinuria. DIAGNOSES: Combined with clinical manifestatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ji-Yu, Cui, Jing-Jing, Yang, Xi-Ran, Li, Yan-Fang, Zhang, Yan-Hua, Chen, Jia-Ni, Lin, Jun-Yu, Zhao, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615339/
https://www.ncbi.nlm.nih.gov/pubmed/34964757
http://dx.doi.org/10.1097/MD.0000000000027890
_version_ 1784604080533929984
author Chen, Ji-Yu
Cui, Jing-Jing
Yang, Xi-Ran
Li, Yan-Fang
Zhang, Yan-Hua
Chen, Jia-Ni
Lin, Jun-Yu
Zhao, Bo
author_facet Chen, Ji-Yu
Cui, Jing-Jing
Yang, Xi-Ran
Li, Yan-Fang
Zhang, Yan-Hua
Chen, Jia-Ni
Lin, Jun-Yu
Zhao, Bo
author_sort Chen, Ji-Yu
collection PubMed
description RATIONALE: Alport syndrome (AS) is an inherited progressive renal failure, characterized by kidney disease, hearing loss, and eye abnormalities. PATIENT CONCERNS: A 7-year-old male child was admitted for persistent microscopic hematuria and proteinuria. DIAGNOSES: Combined with clinical manifestations, laboratory testing, pathological changes of kidney and sequencing results, the patient was diagnosed as AS. INTERVENTIONS: The patient was treated with ACEI and tacrolimus drugs for 2 years, but continued to have hematuria and proteinuria. Thus, a genetic analysis was performed using next-generation sequencing in four affected members from the family. OUTCOMES: The findings revealed triple compound heterozygous mutation of COL4A4: three novel variations, c.1045C>T (p. R349X), c.3505+1G>A (splicing), and c.2165G>A (p. G722D). LESSONS: This study was novel in finding that a triple variant of the COL4A4 gene simultaneously in trans and in cis. The effects of multiple mutation sites and the type of gene mutation in AS were also underlined.
format Online
Article
Text
id pubmed-8615339
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86153392021-11-26 A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report Chen, Ji-Yu Cui, Jing-Jing Yang, Xi-Ran Li, Yan-Fang Zhang, Yan-Hua Chen, Jia-Ni Lin, Jun-Yu Zhao, Bo Medicine (Baltimore) 3500 RATIONALE: Alport syndrome (AS) is an inherited progressive renal failure, characterized by kidney disease, hearing loss, and eye abnormalities. PATIENT CONCERNS: A 7-year-old male child was admitted for persistent microscopic hematuria and proteinuria. DIAGNOSES: Combined with clinical manifestations, laboratory testing, pathological changes of kidney and sequencing results, the patient was diagnosed as AS. INTERVENTIONS: The patient was treated with ACEI and tacrolimus drugs for 2 years, but continued to have hematuria and proteinuria. Thus, a genetic analysis was performed using next-generation sequencing in four affected members from the family. OUTCOMES: The findings revealed triple compound heterozygous mutation of COL4A4: three novel variations, c.1045C>T (p. R349X), c.3505+1G>A (splicing), and c.2165G>A (p. G722D). LESSONS: This study was novel in finding that a triple variant of the COL4A4 gene simultaneously in trans and in cis. The effects of multiple mutation sites and the type of gene mutation in AS were also underlined. Lippincott Williams & Wilkins 2021-11-24 /pmc/articles/PMC8615339/ /pubmed/34964757 http://dx.doi.org/10.1097/MD.0000000000027890 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 3500
Chen, Ji-Yu
Cui, Jing-Jing
Yang, Xi-Ran
Li, Yan-Fang
Zhang, Yan-Hua
Chen, Jia-Ni
Lin, Jun-Yu
Zhao, Bo
A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report
title A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report
title_full A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report
title_fullStr A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report
title_full_unstemmed A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report
title_short A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report
title_sort novel compound heterozygous col4a4 mutation in a chinese family with alport syndrome: a care case report
topic 3500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615339/
https://www.ncbi.nlm.nih.gov/pubmed/34964757
http://dx.doi.org/10.1097/MD.0000000000027890
work_keys_str_mv AT chenjiyu anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT cuijingjing anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT yangxiran anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT liyanfang anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT zhangyanhua anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT chenjiani anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT linjunyu anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT zhaobo anovelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT chenjiyu novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT cuijingjing novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT yangxiran novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT liyanfang novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT zhangyanhua novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT chenjiani novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT linjunyu novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport
AT zhaobo novelcompoundheterozygouscol4a4mutationinachinesefamilywithalportsyndromeacarecasereport